Newsroom
Sorted by: Latest
-
EloElo Group Raises $80 Million in Series C Led by Hornbill Capital and NBCUniversal to Reimagine Mobile Entertainment for the Next Billion Users
BENGALURU, India--(BUSINESS WIRE)--EloElo Group today announced an $80 million Series C led by Hornbill Capital and NBCUniversal....
-
AdvanSix Announces Third Quarter 2026 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Third Quarter 2026 Financial Results...
-
Ralliant Reports Third Quarter 2026 Results and Raises Full Year Guidance
RALEIGH, N.C.--(BUSINESS WIRE)--Ralliant Corporation (“Ralliant” or the “Company”) (NYSE: RAL) today announced financial results for the third quarter of 2026. For the third quarter, revenue of $620 million was up 17% year-over-year on both a total and organic basis. Net earnings were $86 million, and adjusted net earnings were $104 million, resulting in EPS increasing 117% year-over-year to $0.77 and adjusted EPS increasing 64% year-over-year on a normalized basis1 to $0.93. Net earnings margi...
-
ESAB Corporation Announces Third Quarter 2026 Results
NORTH BETHESDA, Md.--(BUSINESS WIRE)--ESAB Corporation Announces Third Quarter 2026 Results...
-
Versigent Reports Third Quarter 2026 Results
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its third quarter ended September 30, 2026. Highlights Third Quarter 2026 Net sales of $2,450 million, up 7.2% year-over-year Adjusted Net Sales Growth1 of approximately 1% year-over-year Net income attributable to Versigent of $102 million Diluted earnings per share (“EPS”) of $1.41, Adjusted Diluted...
-
Eagle Materials Reports Second Quarter Results
DALLAS--(BUSINESS WIRE)--Eagle Materials Inc. (NYSE: EXP) today reported financial results for the second quarter of fiscal 2027 ended September 30, 2026. Notable items for the quarter are highlighted below (unless otherwise noted, all comparisons are with the prior year’s fiscal second quarter): Second Quarter Fiscal 2027 Highlights Record Revenue of $652.7 million Net Earnings of $111.5 million Net Earnings per diluted share of $3.63 Adjusted EBITDA of $202.7 million Adjusted EBITDA is a non-...
-
Trane Technologies to Present at the Baird Global Industrial Conference
SWORDS, Ireland--(BUSINESS WIRE)--Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will participate in a fireside chat at the Baird Global Industrial Conference. They will speak at 9:40 AM CT on Thursday, November 12, 2026. The live webcast will be accessible on the Trane Technologies website at www.tranetechnologies.com under the investor relations section. An archive of the webcast will be available for 30 days following the event. About Tr...
-
TPG Mortgage Investment Trust, Inc. Reports Third Quarter 2026 Results
NEW YORK--(BUSINESS WIRE)--TPG Mortgage Investment Trust, Inc. ("MITT," "we," the "Company," or "our") (NYSE: MITT) today reported financial results for the quarter ended September 30, 2026. MANAGEMENT REMARKS “Despite a challenging September, we remained focused on executing our core residential strategies, sponsoring three home equity securitizations and rotating capital into higher-returning residential credit,” said T.J. Durkin, Chief Executive Officer and President. “Looking ahead, we beli...
-
Compass Pathways to Participate in Stifel 2026 Healthcare Conference on November 11th
LONDON & JERSEY CITY, N.J.--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Stifel 2026 Healthcare Conference on November 11, 2026 and will participate in a fireside chat at 8:40am ET. A live audio webcast of the fireside chat will be accessible at the following link: https://event.summitcast.com/view/4aFtJriVa3BvDmNqmfSxma/k5kw3HNd3Rg...
-
United Therapeutics Corporation Reports Third Quarter 2026 Financial Results
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30, 2026. Total revenues in the third quarter of 2026 increased by four percent year-over-year to $832.5 million, compared to $799.5 million in the third quarter of 2025. “United Therapeutics is entering a period of extraordinary growth. We are advancing a portfolio of new therapies...